Cart summary

You have no items in your shopping cart.

    Human IL17A protein

    Catalog Number: orb594788

    DispatchUsually dispatched within 1-2 weeks
    $ 4,119.00
    Catalog Numberorb594788
    CategoryProteins
    DescriptionRecombinant Human Interleukin-17A(IL17A) (Active)
    TagC-terminal 6xHis-tagged
    Form/AppearanceLyophilized powder
    PurityGreater than 95% as determined by SDS-PAGE.
    MW15.9kDa
    UniProt IDQ16552
    Protein SequenceGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA
    Protein LengthFull Length of Mature Protein
    SourceMammalian cell
    Biological OriginHomo sapiens (Human)
    Biological ActivityThe ED50 as determined by its ability to induce IL-6 secretion by NIH‑3T3 mouse embryonic fibroblast cells is less than 500 ng/ml.
    Expression Region24-155aa
    EndotoxinsLess than 1.0 EU/µg as determined by LAL method.
    StorageThe shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of liquid form is 6 months at -20℃/-80℃. The shelf life of lyophilized form is 12 months at -20℃/-80℃.
    Buffer/PreservativesLyophilized from a 0.2 μm filtered 20 mM PB, 150 mM NaCl, pH 7.4
    Alternative namesInterleukin-17A; IL-17; IL-17A; Cytotoxic T-Lympho
    Read more...
    BackgroundInterleukin-17 is a potent pro-inflammatory cytokine produced by activated memory T cells. There are at least six members of the IL-17 family in humans and in mice. As IL-17 shares properties with IL-1 and TNF-alpha, it may induce joint inflammation and bone and cartilage destruction. This cytokine is found in synovial fluids of patients with rheumatoid arthritis, and produced by rheumatoid arthritis synovium. It increases IL-6 production, induces collagen degradation and decreases collagen synthesis by synovium and cartilage and proteoglycan synthesis in cartilage. IL-17 is also able to increase bone destruction and reduce its formation. Blocking of interleukin-17 with specific inhibitors provides a protective inhibition of cartilage and bone degradation.
    NoteFor research use only
    Application notesFull Length of Mature Protein
    Expiration Date6 months from date of receipt.
    Human IL17A protein

    (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.

    • Human IL17A Protein [orb1476713]

      Greater than 95% as determined by SDS-PAGE.

      15.9 kDa

      Baculovirus

      20 μg, 100 μg, 1 mg
    • Human IL17A protein [orb594787]

      Greater than 95% as determined by SDS-PAGE.

      15.26 kDa

      E.coli

      500 μg, 1 mg, 10 μg, 50 μg
    • Human IL17 ELISA Kit [orb776474]

      Human

      15.63-1000 pg/mL

      5.5 pg/mL

      48 Test, 96 Test, 24 t
    • Human IL17A protein [orb391929]

      ELISA,  MS,  SDS-PAGE,  WB

      Greater than 95% as determined by RP-HPLC and reducing SDS-PAGE.

      E. coli

      500 μg, 50 μg, 10 μg
    • Human IL17A protein [orb391930]

      ELISA,  MS,  SDS-PAGE,  WB

      Greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE.

      Human cells

      500 μg, 50 μg, 10 μg
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars